Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer (ANITA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03598270
Recruitment Status : Recruiting
First Posted : July 26, 2018
Last Update Posted : November 4, 2020
Sponsor:
Collaborators:
Hoffmann-La Roche
GSK/TESARO
AGO Study Group
Belgian Gynaecological Oncology Group
ARCAGY/ GINECO GROUP
The Israeli Society of Gynecologic Oncology
MaNGO
Information provided by (Responsible Party):
Grupo Español de Investigación en Cáncer de Ovario